Preprandial microemulsion cyclosporine administration is effective for patients with refractory nephrotic syndrome

Clinical and Experimental Nephrology

Volumn 13, Issue 2, 2009, Pages 123-129

  Shirai, Sayuri ^a   Yasuda, Takashi ^a   Tsuchida, Hiroki ^a   Kuboshima, Shingo ^a   Konno, Yusuke ^a   Shima, Yoshinori ^a   Sato, Takeo ^a   Hatta, Shigeo ^a   Masuhara, Keisou ^a   Kimura, Kenjirou ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Microemulsion cyclosporine; Preprandial administration; Refractory nephrotic syndrome

Indexed keywords

CYCLOSPORIN A;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SCREENING; HUMAN; MICROEMULSION; NEPHROTIC SYNDROME; NEPHROTOXICITY; POSTPRANDIAL STATE; REMISSION; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; CYCLOSPORINE; EMULSIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL ABSORPTION; MIDDLE AGED; NEPHROSIS, LIPOID; POSTPRANDIAL PERIOD; YOUNG ADULT;

EID: 67349102777     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-008-0112-z     Document Type: Article

References (11)

1. H Tanaka T Nakahata E Ito 2004 Single-dose daily administration of cyclosporin A for relapsing nephrotic syndrome Pediatr Nephrol 19 1055 8 (Pubitemid 39242791)
2. GM Ghiggeri P Catarsi F Scolari G Caridi R Bertelli A Carrea S Sanna-Cherchi F Emma L Allegri G Cancarini GF Rizzoni F Perfumo 2004 Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study Clin Ther 26 1411 8 (Pubitemid 39572155)
3. T Kusaba Y Konno S Hatta T Fujino T Yasuda H Miura H Sasaki J Okabayashi M Murao T Sakurada G Imai S Shirai S Kuboshima Y Shima G Ogimoto T Sato K Masuhara K Kimura 2005 More stable and reliable pharmacokinetics with preprandial administration of cyclosporine compared with postprandial administration in patients with refractory nephrotic syndrome Pharmacotherapy 25 52 8 (Pubitemid 40054033)
4. W Mraz C Muller B Molnar M Knedel 1989 Analysis of cyclosporin A (CsA) concentrations by fluorescence polarization immunoassay (FPIA): comparison with radio immunoassay (RIA) and liquid chromatography (HPLC) Transplant Proc 21 885 7 (Pubitemid 19118259)
5. GM Dalere BL Lum GF Cooney M Wong-Chin 1995 Comparison of three methods for cyclosporine area under the curve monitoring calculations Ther Drug Monit 17 305 7
6. DC Cattran GB Appel LA Hebert LG Hunsicker MA Pohl WE Hoy DR Maxwell CL Kunis 2001 Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial Kidney Int 59 1484 90 (Pubitemid 32281239)
7. G Filler 2005 How should microemulsified Cyclosporine A (Neoral) therapy in patients with nephrotic syndrome be monitored? Nephrol Dial Transplant 20 1032 4 (Pubitemid 40862088)
8. L Kung TD Batiuk S Palomo-Pinon J Noujaim LM Helms PF Halloran 2001 Tissue distribution of calcineurin and its sensitivity to inhibition by cyclosporine Am J Transplant 1 325 33 (Pubitemid 33681696)
9. PF Halloran LM Helms L Kung J Noujaim 1999 The temporal profile of calcineurin inhibition by cyclosporine in vivo Transplantation 68 1356 61
10. T Rainiene L Papinigiene A Laurinavicius 2003 [Nephrotoxicity of cyclosporin A after kidney transplantation] Medicina (Kaunas) 39 Suppl 1 161 5
11. A Tarantino P Passerini M Campise E Bonizzoni F Ceccarini G Montagnino A Aroldi C Ponticelli 2004 Is cyclosporine in renal-transplant recipients more effective when given twice a day than in a single daily dose? Transplantation 78 675 80 (Pubitemid 39244727)